ReviewBiomolecules2022

Immune Checkpoint Inhibitors and RAS-ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma.

Marta Morante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.